Literature DB >> 1383855

Evaluation of therapeutically induced hypertension in patients with delayed cerebral vasospasm by xenon-enhanced computed tomography.

H Touho1, J Karasawa, H Ohnishi, H Shishido, K Yamada, K Shibamoto.   

Abstract

Serial cerebral blood flow (CBF) measurements were made with stable xenon-enhanced computed tomography in 20 patients with angiographically confirmed ruptured intracranial aneurysms, before and during induced hypertension with continuous infusion of dopamine. All patients showed angiographic vasospasm during their course. Twelve patients without symptomatic vasospasm (Group 1) had the lowest hemispheric CBF on the craniotomy side of 31.6 +/- 6.8 ml/100 gm/min on days 4-9 (control value, 40.1 +/- 2.0 ml/100 gm/min), while the other eight patients with symptomatic vasospasm (Group 2) had the lowest hemispheric CBF on the craniotomy side of 25.0 +/- 7.6 ml/100 gm/min on days 10-14. The critical hemispheric CBF inducing neurological deficits was about 20 ml/100 gm/min in Group 2. Dysautoregulation was usually present in Groups 1 and 2, but therapeutically induced hypertension could reverse the delayed neurological deficits, if begun early at the stage of delayed vasospasm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383855     DOI: 10.2176/nmc.32.671

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  7 in total

Review 1.  Hemodynamic management of subarachnoid hemorrhage.

Authors:  Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 2.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

Review 3.  Routine management of volume status after aneurysmal subarachnoid hemorrhage.

Authors:  Stefan Wolf
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 4.  Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Authors:  Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 5.  Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.

Authors:  Julia C Durrant; Holly E Hinson
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 6.  Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.

Authors:  Jan W Dankbaar; Arjen Jc Slooter; Gabriel Je Rinkel; Irene C van der Schaaf
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

7.  The Effects of Cerebral Vasospasm on Cerebral Blood Flow and the Effects of Induced Hypertension: A Mathematical Modelling Study.

Authors:  Pervinder Bhogal; Leonard Leong Yeo; Lucas O Müller; Pablo J Blanco
Journal:  Interv Neurol       Date:  2019-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.